Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	432.63	5.70	1.07
Graham Fair Price	-35.72	20779.95	32329.27
PEG	-55.06	-0.13	0.28
Price/Book	3.18	0.31	0.30
Price/Cash Flow	900.65	58.19	5.82
Prices/Earnings	149.10	7.37	2.96
Price/Sales	19.76	0.82	0.69
Price/FCF	900.65	58.19	5.82
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-4.01	0.08	0.08
Operating Margin	0.28	0.02	0.02
ROA	-58.81	< 0.005	0.02
ROE	0.03	0.01	-58.58
ROIC	0.02	< 0.005	-64.87
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	0.42	-99.56
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.71	-0.14	80.76
EPS QOQ	0.11	-0.59	454.35
FCF QOQ	0.48	-0.90	85.15
Revenue QOQ	0.06	-0.14	150.23
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	48.89	61.79	26.38
Days Sales Outstanding (DSO)	33.29	39.96	20.02
Inventory Turnover	1.84	1.46	-20.87
Debt/Capitalization	0.03	0.03	3.19
Quick Ratio	1.92	1.75	-8.57
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	42958.69	42902.75	-0.13
Cash	19937.82	19595.08	-1.72
Capex	-498.40	-656.38	-31.70
Free Cash Flow	2200.94	226.65	-89.70
Revenue	18585.37	15991.07	-13.96
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.62	2.44	-7.07
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-13.44	-12.84	4.46
Naive Interpretation	Member

06 - Financial Health · Bad

Rating